ASTRO balks at proposed cuts
Radiologists are not the only ones feeling the pinch from Medicare. Their colleagues on the radiation oncology side of the fence stand to lose out as well, if proposed Medicare rules go through – and the American Society for Radiation Oncology (ASTRO) is kicking up some dust about it.
ASTRO balks at proposed cuts
Radiologists are not the only ones feeling the pinch from Medicare. Their colleagues on the radiation oncology side of the fence stand to lose out as well, if proposed Medicare rules go through – and the American Society for Radiation Oncology (ASTRO) is kicking up some dust about it. This week ASTRO officially requested the Centers for Medicare and Medicaid Services (CMS) not to adopt proposed changes to the Medicare policies and payment rates for physician services, changes that it says could drastically cut reimbursements for radiation therapy services. If a proposed rule in the Medicare physician fee schedule takes effect, the utilization rate for radiation therapy equipment would jump to 90% from the current level of 50%, drastically cutting reimbursement for services, according to ASTRO. The rule does not single out radiation oncology, but rather applies to any medical equipment costing more than $1 million. Organized radiology has posed similar objections to the proposed rule change.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
